NCT03899298 · Phase 1 · NOT YET RECRUITING
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
This trial is testing whether injections of tissue derived from amniotic membranes and umbilical cords are safe and whether they improve quality of life across a wide range of conditions, including Alzheimer's disease. It is a Phase 1 trial, meaning the primary goal is checking for safety, not proving the treatment works. Alzheimer's is one of roughly a dozen conditions lumped together here, which makes it a very broad study.
You may qualify if
- Age 18 and over.
- Ability to attend follow up visits or at least converse on phone or complete email follow up forms.
- Competent to understand the study protocol and provide voluntary informed consent.
- Patients with any of the following conditions: Arthritis (Degenerative, Rheumatoid, Psoriatic, Lupus, Gout), Sports or Overuse Injuries (e.g. Rotator Cuff injury, Tennis Elbow), Chronic Kidney Disease (may be on dialysis), Back/Neck Pain, Erectile Dysfunction, Peyronie's Disease, Alzheimer's Disease, Parkinson's Disease, Neuropathy, Post-Stroke, Post-Concussion Syndrome, COPD, Emphysema, Pulmonary Fibrosis, Post myocardial infarction (at least 6 months out), Cardiomyopathy, Congestive Heart Failure.
You're excluded if
- Active Cancer
- Pregnancy, Lactating
- Severe Clotting disorder
- Myocardial Infarction less than six months ago.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2019-08-22